Reported 26 days ago
Cigna CEO David Cordani stated that the US is the only developed nation debating insurance coverage for GLP-1 weight-loss drugs. While about 50% of large employers provide coverage, concerns about side effects and long-term efficacy have led to rising costs and short-term use among patients. Cordani emphasized that current weight management benefits may not justify their costs, highlighting the need for careful consideration before expanding coverage.
Source: YAHOO